FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2787873669> ?p ?o ?g. }

• W2787873669 endingPage "1593" @default.
• W2787873669 startingPage "1586" @default.
• W2787873669 abstract "Abstract Purpose: The European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer (NMIBC) recommend risk stratification based on clinicopathologic parameters. Our aim was to investigate the added value of biomarkers to improve risk stratification of NMIBC. Experimental Design: We prospectively included 1,239 patients in follow-up for NMIBC in six European countries. Fresh-frozen tumor samples were analyzed for GATA2, TBX2, TBX3, and ZIC4 methylation and FGFR3, TERT, PIK3CA, and RAS mutation status. Cox regression analyses identified markers that were significantly associated with progression to muscle-invasive disease. The progression incidence rate (PIR = rate of progression per 100 patient-years) was calculated for subgroups. Results: In our cohort, 276 patients had a low, 273 an intermediate, and 555 a high risk of tumor progression based on the EAU NMIBC guideline. Fifty-seven patients (4.6%) progressed to muscle-invasive disease. The limited number of progressors in this large cohort compared with older studies is likely due to improved treatment in the past two decades. Overall, wild-type FGFR3 and methylation of GATA2 and TBX3 were significantly associated with progression (HR = 0.34, 2.53, and 2.64, respectively). The PIR for EAU high-risk patients was 4.25. On the basis of FGFR3 mutation status and methylation of GATA2, this cohort could be reclassified into a good class (PIR = 0.86, 26.2% of patients), a moderate class (PIR = 4.32, 49.7%), and a poor class (PIR = 7.66, 24.0%). Conclusions: We conclude that the addition of selected biomarkers to the EAU risk stratification increases its accuracy and identifies a subset of NMIBC patients with a very high risk of progression. Clin Cancer Res; 24(7); 1586–93. ©2018 AACR." @default.
• W2787873669 created "2018-02-23" @default.
• W2787873669 creator A5007134818 @default.
• W2787873669 creator A5011658550 @default.
• W2787873669 creator A5013372630 @default.
• W2787873669 creator A5016485880 @default.
• W2787873669 creator A5024296406 @default.
• W2787873669 creator A5027336843 @default.
• W2787873669 creator A5030908792 @default.
• W2787873669 creator A5037804113 @default.
• W2787873669 creator A5038176751 @default.
• W2787873669 creator A5039402380 @default.
• W2787873669 creator A5043923733 @default.
• W2787873669 creator A5048285441 @default.
• W2787873669 creator A5049585448 @default.
• W2787873669 creator A5052198366 @default.
• W2787873669 creator A5059297987 @default.
• W2787873669 creator A5060014046 @default.
• W2787873669 creator A5066148411 @default.
• W2787873669 creator A5075555997 @default.
• W2787873669 creator A5078075714 @default.
• W2787873669 creator A5079523749 @default.
• W2787873669 creator A5080250383 @default.
• W2787873669 creator A5082200538 @default.
• W2787873669 creator A5082719104 @default.
• W2787873669 creator A5090521905 @default.
• W2787873669 creator A5091711361 @default.
• W2787873669 date "2018-04-01" @default.
• W2787873669 modified "2023-10-01" @default.
• W2787873669 title "Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups" @default.
• W2787873669 cites W2002045993 @default.
• W2787873669 cites W2004038947 @default.
• W2787873669 cites W2011595291 @default.
• W2787873669 cites W2032005128 @default.
• W2787873669 cites W2035297454 @default.
• W2787873669 cites W2037369392 @default.
• W2787873669 cites W2057691584 @default.
• W2787873669 cites W2079542321 @default.
• W2787873669 cites W2099900006 @default.
• W2787873669 cites W2119362132 @default.
• W2787873669 cites W2126538910 @default.
• W2787873669 cites W2143033064 @default.
• W2787873669 cites W2146391374 @default.
• W2787873669 cites W2147847895 @default.
• W2787873669 cites W2160129064 @default.
• W2787873669 cites W2301685087 @default.
• W2787873669 cites W2426844253 @default.
• W2787873669 cites W2620920447 @default.
• W2787873669 cites W2916183155 @default.
• W2787873669 doi "https://doi.org/10.1158/1078-0432.ccr-17-2719" @default.
• W2787873669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29367430" @default.
• W2787873669 hasPublicationYear "2018" @default.
• W2787873669 type Work @default.
• W2787873669 sameAs 2787873669 @default.
• W2787873669 citedByCount "69" @default.
• W2787873669 countsByYear W27878736692018 @default.
• W2787873669 countsByYear W27878736692019 @default.
• W2787873669 countsByYear W27878736692020 @default.
• W2787873669 countsByYear W27878736692021 @default.
• W2787873669 countsByYear W27878736692022 @default.
• W2787873669 countsByYear W27878736692023 @default.
• W2787873669 crossrefType "journal-article" @default.
• W2787873669 hasAuthorship W2787873669A5007134818 @default.
• W2787873669 hasAuthorship W2787873669A5011658550 @default.
• W2787873669 hasAuthorship W2787873669A5013372630 @default.
• W2787873669 hasAuthorship W2787873669A5016485880 @default.
• W2787873669 hasAuthorship W2787873669A5024296406 @default.
• W2787873669 hasAuthorship W2787873669A5027336843 @default.
• W2787873669 hasAuthorship W2787873669A5030908792 @default.
• W2787873669 hasAuthorship W2787873669A5037804113 @default.
• W2787873669 hasAuthorship W2787873669A5038176751 @default.
• W2787873669 hasAuthorship W2787873669A5039402380 @default.
• W2787873669 hasAuthorship W2787873669A5043923733 @default.
• W2787873669 hasAuthorship W2787873669A5048285441 @default.
• W2787873669 hasAuthorship W2787873669A5049585448 @default.
• W2787873669 hasAuthorship W2787873669A5052198366 @default.
• W2787873669 hasAuthorship W2787873669A5059297987 @default.
• W2787873669 hasAuthorship W2787873669A5060014046 @default.
• W2787873669 hasAuthorship W2787873669A5066148411 @default.
• W2787873669 hasAuthorship W2787873669A5075555997 @default.
• W2787873669 hasAuthorship W2787873669A5078075714 @default.
• W2787873669 hasAuthorship W2787873669A5079523749 @default.
• W2787873669 hasAuthorship W2787873669A5080250383 @default.
• W2787873669 hasAuthorship W2787873669A5082200538 @default.
• W2787873669 hasAuthorship W2787873669A5082719104 @default.
• W2787873669 hasAuthorship W2787873669A5090521905 @default.
• W2787873669 hasAuthorship W2787873669A5091711361 @default.
• W2787873669 hasBestOaLocation W27878736691 @default.
• W2787873669 hasConcept C121608353 @default.
• W2787873669 hasConcept C126322002 @default.
• W2787873669 hasConcept C142724271 @default.
• W2787873669 hasConcept C143998085 @default.
• W2787873669 hasConcept C188816634 @default.
• W2787873669 hasConcept C201903717 @default.
• W2787873669 hasConcept C2775910329 @default.
• W2787873669 hasConcept C2779256057 @default.
• W2787873669 hasConcept C2780182762 @default.
• W2787873669 hasConcept C2780352672 @default.

• next